Product Information
TERBINAFINE HCL 250 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.1356 per EA under NDC 69097085907. Its NADAC has been published 524 times since Aug 10, 2016.
FDA first approved this application on Jul 2, 2007.
Strength
250 mg/1
Manufacturer
Cipla USA Inc.NDC
69097085907
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TERBINAFINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077533FDA Approved
7/2/2007
On Market Since
6/27/2016
Pharmacological Classes
Price Statistics
The NADAC for TERBINAFINE HCL 250 MG TABLET has been published 524 times since Aug 10, 2016, and over the history we have for it it has declined 12.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1356 per EA |
|---|---|
| All-time high | $0.1777 (Aug 11, 2021) |
| All-time low | $0.1158 (Nov 20, 2024) |
| 52-week high | $0.1513 |
| 52-week low | $0.1324 |
| Median price | $0.1541 |
| Average price | $0.1538 |
| Largest weekly change | -21.1% (Nov 20, 2024) |
| Weeks tracked | 524 |
| Tracking since | Aug 10, 2016 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TERBINAFINE HCL 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TERBINAFINE HCL 250 MG TABLET, manufactured by Cipla USA Inc., is $0.1356 per EA (NDC 69097085907), effective Aug 19, 2026.
How has the price of TERBINAFINE HCL 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for TERBINAFINE HCL 250 MG TABLET has declined 12.5%. It has been tracked across 524 weekly CMS publications since Aug 10, 2016.
What are the highest and lowest recorded NADAC prices for TERBINAFINE HCL 250 MG TABLET?
Since Aug 10, 2016, the NADAC for TERBINAFINE HCL 250 MG TABLET has ranged from a low of $0.1158 (Nov 20, 2024) to a high of $0.1777 (Aug 11, 2021), with a median of $0.1541 per EA.
Are there cheaper alternatives to TERBINAFINE HCL 250 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TERBINAFINE HCL 250 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TERBINAFINE HCL 250 MG TABLET?
TERBINAFINE HCL 250 MG TABLET (NDC 69097085907) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.